In a filing, Centessa Pharmaceuticals plc ADR revealed its Chief Executive Officer SAHA SAURABH unloaded Company’s shares for reported $0.92 million on Mar 20 ’25. In the deal valued at $16.69 per share,55,000 shares were sold. As a result of this transaction, SAHA SAURABH now holds 276,017 shares worth roughly $4.59 million.
Then, SAHA SAURABH bought 55,000 shares, generating $899,250 in total proceeds.
Before that, CHAO DAVID M sold 7,000 shares. Centessa Pharmaceuticals plc ADR shares valued at $120,206 were divested by the Chief Administrative Officer at a price of $17.17 per share. As a result of the transaction, CHAO DAVID M now holds 225,007 shares, worth roughly $3.74 million.
TD Cowen initiated its Centessa Pharmaceuticals plc ADR [CNTA] rating to a Buy in a research note published recently. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who increased its forecast for the stock in mid September from “an Equal-weight” to “an Overweight”. B. Riley Securities began covering CNTA with “Buy” recommendation on September 19, 2024. Oppenheimer started covering the stock on July 18, 2024. It rated CNTA as “an Outperform”.
Price Performance Review of CNTA
On Monday, Centessa Pharmaceuticals plc ADR [NASDAQ:CNTA] saw its stock jump 5.59% to $16.63. Over the last five days, the stock has lost -3.31%. Centessa Pharmaceuticals plc ADR shares have fallen nearly -0.72% since the year began. Nevertheless, the stocks have risen 40.46% over the past one year. While a 52-week high of $19.09 was reached on 02/07/25, a 52-week low of $7.75 was recorded on 01/14/25. SMA at 50 days reached $16.47, while 200 days put it at $14.54.
Levels Of Support And Resistance For CNTA Stock
The 24-hour chart illustrates a support level at 15.80, which if violated will result in even more drops to 14.97. On the upside, there is a resistance level at 17.16. A further resistance level may holdings at 17.70. The Relative Strength Index (RSI) on the 14-day chart is 50.95, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.38, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 50.19%. Stochastics %K at 41.28% indicates the stock is a holding.
How much short interest is there in Centessa Pharmaceuticals plc ADR?
A steep rise in short interest was recorded in Centessa Pharmaceuticals plc ADR stocks on 2025-02-28, growing by 2.41 million shares to a total of 5.46 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 3.05 million shares. There was a rise of 44.1%, which implies that there is a positive sentiment for the stock.
